The COVID-19 pandemic has laid bare the fragility of the global system of preparedness and response to pandemics and the fragmentation of our research and development ecosystem. The pandemic has provided a disruptive moment to advance new norms and frameworks for influenza. It also has demonstrated how innovative global public-private partnerships and coordination mechanisms can lead to rapid successes in viral vaccine research, manufacturing, and risk pooling.


Countering the Pandemic Threat Through Global Coordination on Vaccines identifies ways to strengthen pandemic and seasonal influenza global coordination, partnerships, and financing. This report presents seven overarching recommendations for how the urgent influenza threat should be conceptualized and prioritized within the global pandemic preparedness and response agenda in the future.


Table of Contents


Front Matter
Summary
1 Introduction: The Imperative for Global Investment in Influenza
Vaccines
2 The Existing Global Governance Landscape for Influenza Vaccines
3 Pathogen Sharing for Influenza Vaccine Production
4 Technology and Manufacturing Partnerships
5 Influenza Vaccine Access and Financing
6 Recommendations and the Path Forward
Appendix A: Committee and Staff Biographies
Appendix B: Committee Meeting Agendas